Blog
RSS FeedPosted by Michael Wonder on 14 Jun 2023
Snap Spanish elections throw health reimbursement reform into doubt
13 June 2023 - Two broad health reform initiatives are affected by the election. ...
Posted by Michael Wonder on 29 Mar 2023
Hansa Biopharma announces positive reimbursement decision in Spain for Idefirix (imlifidase) as desensitisation treatment for highly sensitised patients in kidney transplantation
29 March 2023 - Hansa Biopharma today announced that the Spanish Minister of Health (Ministerio de Sanidad) has granted access and ...
Posted by Michael Wonder on 11 Jan 2023
Lupin and Exeltis announce reimbursement approval of NaMuscla in Spain for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic disorders
9 January 2023 - Agreement enables sustainable patient access of the only EU approved treatment for myotonia symptoms in non-dystrophic ...
Posted by Michael Wonder on 22 Nov 2021
Vertex announces reimbursement agreement in Spain for Kaftrio (ivacaftor/tezacaftor/elexacaftor) in combination with ivacaftor to treat people with cystic fibrosis 12 years and older with at least one F508del mutation in the CFTR gene
19 November 2021 - With this reimbursement agreement approximately 700 people with cystic fibrosis now have access to a CFTR ...
Posted by Michael Wonder on 10 Aug 2021
Characterisation of the pharmaceutical risk sharing arrangement process in Catalonia
10 August 2021 - Pharmaceutical risk sharing arrangements have emerged as a reasonable tool to promote sustainable access to innovative medicines ...
Posted by Michael Wonder on 14 Sep 2020
Evaluation of patient involvement strategies in health technology assessment in Spain: the viewpoint of HTA researchers
11 September 2020 - The Spanish Network of Agencies for Assessing National Health System Technologies and Performance defined a patient involvement ...
Posted by Michael Wonder on 04 Mar 2020
Clovis Oncology announces availability and reimbursement for Rubraca (rucaparib) tablets for women with relapsed ovarian cancer in Spain
2 March 2020 - Rucaparib now available in multiple countries across Europe. ...
Posted by Michael Wonder on 17 Mar 2019
Toward a strategy to involve patients in health technology assessment in Spain
14 March 2019 - The aim of this study was to develop a feasible and effective strategy to involve patients in ...
Posted by Michael Wonder on 10 Oct 2018
Digital technology could revolutionise drug reimbursement in Spain
8 October 2018 - Digital technology could play a major role in creating a system that reimburses medicines based on ...
Posted by Michael Wonder on 29 Dec 2017
Estimating a cost-effectiveness threshold for the Spanish NHS
28 December 2017 - The cost of generating a quality-adjusted life year within a National Health Service provides an approximation of ...